Jalil, Lilma K.

HRN: 25-17-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
CEFTRIAXONE 1G (VIAL)
05/30/2024
06/06/2024
IV
2g
OD
CAP
Waiting Final Action 
05/30/2024
AZITHROMYCIN 500MG TABLET (TAB)
05/30/2024
06/03/2024
PO
500
OD
CAP
Waiting Final Action 
06/01/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2024
06/08/2024
IV
4.5g
Q8h
CAP-MR
06/04/2024
LEVOFLOXACIN 500MG (TAB)
06/04/2024
06/10/2024
PO
500mg
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: